An Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Real-World Practice
NCT05494606
·
clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
785
Enrollment
INDUSTRY
Sponsor class
Conditions
Ulcerative Colitis
Sponsor
AbbVie